TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 3610, "Food and Drug Import Safety Act of 2007"; S. 242, HR 380, "Pharmaceutical Market Access and Drug Safety Act of 2007"; H.R.2606 and S1736 "340B Program Improvement and Integrity Act of 2007"; HR 2680 "Health Care Access and Rural Equity Act of 2007"; S251 "Pharmaceutical Market Access Act of 2007"; S242 and HR380 "Pharmaceutical Market Access and Drug Safety Act of 2007" (provisions related to proposed changes to the 340B federal drug pricing program).
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medicare/Medicaid MMM
Issues and provisions related to the disclosure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007" and S1607, "The Children's Health Insurance Program Reauthorization Act of 2007." Coding and reimbursement of coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues related to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007"; issues related to osteoporosis prevention, awareness, and screening. H.R. 6331, S. 3101, Medicare Improvements for Patients and Providers Act of 2008.
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medical/Disease Research/Clinical Labs MED
Issues related to follow-on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580. "The Food and Drug Administration Amendment Act of 2007", and HR3610 "Food and Drug Safety Act of 2007"; HR 1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.
Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.